-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H87iRcwm4aP2mmXIFaNq/Xe7JKwXkdnPTYNvUGTmKKIvfy9CUuRgn0kzUS0MAJqR ygIoPc8R+3S6+iwWS67biQ== 0000950133-02-000521.txt : 20020414 0000950133-02-000521.hdr.sgml : 20020414 ACCESSION NUMBER: 0000950133-02-000521 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20011231 FILED AS OF DATE: 20020214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-06964 FILM NUMBER: 02549373 BUSINESS ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 13F-HR 1 w57606e13f-hr.txt FORM 13F FOR BB BIOTECH AG UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for Calendar Year or Quarter Ended: December 31, 2001 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Schaffhausen Switzerland CH-8200 Form 13F File Number: 28-6964 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: R. Di Girolamo Title: SIGNING AUTHORITY ---------------- Phone: (41-41) 724-5959 Signature, Place, and Date of Signing: /s/ RUBINO DI GIROLAMO ---------------------------- Zug, Switzerland, February 14, 2002 Report Type (Check only one.): [ ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [X] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: Name Biotech Focus N.V. Biotech Invest N.V. Biotech Target N.V. Biotech Growth N.V. Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 4 Form 13F Information Table Entry Total: 21 Form 13F Information Table Value Total: $1,733,442 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Name 1 Biotech Focus N.V. 2 Biotech Invest N.V. 3 Biotech Target N.V. 4 Biotech Growth N.V. BB BIOTECH AG FORM 13F INFORMATION TABLE
- ----------------------------------------------------------------------------------------------------------------------- COLUMN 8: VOTING AUTHORITY COLUMN 4: COLUMN 5: COLUMN 1: COLUMN 2: COLUMN 3: VALUE ------------------- COLUMN 6: - -------------------------- INVESTMENT COLUMN 7: ---------------------- NAME OF ISSUER TITLE OF CLASS CUSIP (X$1,000) SHRS OR SH/ PUT/ DISCRETION OTHER PRN AMT PRN CALL MANAGERS SOLE SHARED NONE - ---------------------------------------------------------------------------------------------------------------------- Adolor Corp. Common Stock 00724X102 $ 29,501 1,742,500 SH DEFINED 3 1,742,500 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Amgen Inc. Common Stock 00075886F1 $ 309,009 5,475,000 SH DEFINED 1 5,475,000 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Aviron Common Stock 05376210 $ 152,422 3,065,000 SH DEFINED 2 3,065,000 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- CV Therapeutics, Inc. Common Stock 12666710 $ 75,073 1,443,147 SH DEFINED 3 1,443,147 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Cell Therapeutics, Inc. Common Stock 150934107 $ 22,138 920,500 SH DEFINED 3 920,500 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Cubist Pharmaceuticals, Common Stock 229678107 $ 28,948 805,000 SH DEFINED 3 805,000 NONE NONE Inc. - ---------------------------------------------------------------------------------------------------------------------- 3-Dimensional Pharmaceuticals, Inc. Common Stock 88554W104 $ 22,338 3,260,970 SH DEFINED 4 3,260,970 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Durect Corporation Common Stock 266605104 $ 21,828 2,254,957 SH DEFINED 4 2,254,957 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Endo Pharmaceuticals, Inc. Common Stock 29264P104 $ 12,685 1,087,000 SH DEFINED 3 1,087,000 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- GenVec Inc. Common Stock 37246C109 $ 2,174 1,271,185 SH DEFINED 4 1,271,185 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- IDEC Pharmaceuticals Common Stock 449370105 $ 305,498 4,432,000 SH DEFINED 1 4,432,000 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Imclone Common Stock 45245W109 $ 112,636 2,424,361 SH DEFINED 2 2,424,361 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Medicines Company (The) Common Stock 584688105 $ 31,489 5,204,837 SH DEFINED 4 5,204,837 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- MedImmune Common Stock 584699102 $ 514,763 11,106,000 SH DEFINED 1 11,106,000 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Neurocrine Biosciences Common Stock 64125C109 $ 43,019 1,343,500 SH DEFINED 3 1,343,500 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Pozen, Inc. Common Stock 73941U102 $ 2,531 482,000 SH DEFINED 3 482,000 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Regeneron Pharmaceuticals, Inc. Common Stock 75886F107 $ 6,758 240,000 SH DEFINED 3 240,000 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Third Wave Technologies Common Stock 88428W108 $ 7,418 1,173,800 SH DEFINED 4 1,173,800 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Titan Pharmaceuticals, Inc. Common Stock 888314101 $ 3,197 325,900 SH DEFINED 3 325,900 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Transkaryotic Therapies Common Stock 89373510 $ 20,608 481,500 SH DEFINED 2 481,500 NONE NONE - ---------------------------------------------------------------------------------------------------------------------- Virologic Common Stock 92823R201 $ 9,409 3,605,004 SH DEFINED 4 3,605,004 NONE NONE COLUMN TOTALS $1,733,442 - ----------------------------------------------------------------------------------------------------------------------
-----END PRIVACY-ENHANCED MESSAGE-----